Examining Drug Trend: Diabetes
Drug price is driving trend. Overall utilization for the top 10 drug classes in 2016 decreased, while prices increased. To better understand 2016 trend, we will be examining the top 10 therapeutic classes and their trend components, starting with diabetes.
Diabetes: Top PMPY for 2016
Forecast for Diabetes
Utilization of DPP4 inhibitors in diabetes is far greater than other branded agents, outside of insulin, and is expected to maintain this level of utilization. Expect to see more utilization for SGLT2 inhibitors and GLP-1 agonists due to clinical data showing benefits in morbidity and mortality. These new drugs could significantly increase costs in this therapeutic class.